Schizophrenia clinical trials

175 recruiting studies in the US for schizophrenia, a serious mental health condition affecting thinking and perception.

Schizophrenia research here is largely non-drug — cognitive training, peer support, early-intervention and care models — with Phase 3 and Phase 4 medication studies alongside. Drug trials may require a period of stable symptoms or, for acute studies, a short inpatient stay. A family member or caregiver can often help with the process.